Literature DB >> 8223842

Decreased chloramphenicol clearance in malnourished Ethiopian children.

M Ashton1, P Bolme, E Alemayehu, M Eriksson, L Paalzow.   

Abstract

The disposition of chloramphenicol and chloramphenicol monosuccinate has been studied in thirty-four Ethiopian children of varying nutritional status. After a single intravenous dose corresponding to chloramphenicol 25 mg per kg bodyweight, the plasma clearance of chloramphenicol monosuccinate was decreased only in severely malnourished children with kwashiorkor. Seventeen % of the dose (range 0-51%) was recovered in urine as intact prodrug, indicating incomplete and variable bioavailability of chloramphenicol. Compared to underweight children, on average marasmic and kwashiorkor subjects exhibited a 2- and 3-fold increase, respectively, in the AUC of chloramphenicol. Elevated AUCs could be traced to reduced hepatic clearance of the drug. The unbound fraction both of chloramphenicol and its prodrug were slightly elevated in serum from kwashiorkor subjects. The possibility of using a single point measurement of plasma chloramphenicol as a guide to individualized dosage are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8223842     DOI: 10.1007/bf00315503

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  20 in total

1.  Disposition of chloramphenicol in young rhesus monkeys with protein-energy malnutrition.

Authors:  B Sharma; S Mehta; C K Nain; V S Mathur
Journal:  Drug Nutr Interact       Date:  1986

2.  Bioavailability and pharmacokinetics of chloramphenicol palmitate in malnourished children.

Authors:  S Mahta; C K Nain; H K Kalsi; V S Mathur
Journal:  Indian J Med Res       Date:  1981-08       Impact factor: 2.375

3.  Single point clearance estimation.

Authors:  J R Koup; J T Slattery; M Gibaldi
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1979-09

4.  Rapid estimation of chloramphenicol clearance in infants and children.

Authors:  J R Koup; C M Sack; A L Smith; N N Neely; M Gibaldi
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

5.  Chloramphenicol pharmacokinetics in Ethiopian children of differing nutritional status.

Authors:  M Eriksson; L Paalzow; P Bolme; T W Mariam
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Chloramphenicol succinate kinetics in infants and young children.

Authors:  C M Sack; J R Koup; K E Opheim; N Neeley; A L Smith
Journal:  Pediatr Pharmacol (New York)       Date:  1982

7.  Chloramphenicol pharmacokinetics in hospitalized patients.

Authors:  J R Koup; A H Lau; B Brodsky; R L Slaughter
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

8.  Relative bioavailability of intravenous chloramphenicol succinate and oral chloramphenicol palmitate in infants and children.

Authors:  R E Kauffman; M C Thirumoorthi; J A Buckley; M K Aravind; A S Dajani
Journal:  J Pediatr       Date:  1981-12       Impact factor: 4.406

9.  Comparative bioavailability and pharmacokinetics of chloramphenicol after intravenous chloramphenicol succinate in premature infants and older patients.

Authors:  M C Nahata; D A Powell
Journal:  Dev Pharmacol Ther       Date:  1983

Review 10.  Serum level monitoring of antibacterial drugs. A review.

Authors:  M Wenk; S Vozeh; F Follath
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

View more
  2 in total

Review 1.  Antibiotics in severely malnourished children: systematic review of efficacy, safety and pharmacokinetics.

Authors:  Marzia Lazzerini; David Tickell
Journal:  Bull World Health Organ       Date:  2011-05-20       Impact factor: 9.408

2.  Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection.

Authors:  Samuel L M Arnold; Ryan Choi; Matthew A Hulverson; Deborah A Schaefer; Sumiti Vinayak; Rama S R Vidadala; Molly C McCloskey; Grant R Whitman; Wenlin Huang; Lynn K Barrett; Kayode K Ojo; Erkang Fan; Dustin J Maly; Michael W Riggs; Boris Striepen; Wesley C Van Voorhis
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.